905. Reducing Inflammation: State of the Art
Session: Symposium: HIV State of the Art
Friday, October 5, 2018: 9:35 AM
Room: N Hall D
Priscilla Hsue, MD, University of California, San Francisco, San Francisco, CA

My research interest is in the pathogenesis, clinical manifestations, and treatment of cardiovascular disease and inflammation in HIV-infected patients. As Co-Director of the Center for Vascular Excellence at UCSF, I have extensive experience in ultrasound imaging including assessment of carotid artery intima-media thickness and assessment of endothelial function using flow-mediated vasodilation of the brachial artery and have used both of these techniques to study HIV-infected individuals with the purpose of ascertaining the pathophysiology of HIV-related cardiovascular disease and the role of inflammation in this disease process. I have published widely in the area of HIV-related cardiovascular disease and inflammation including high-impact publications in Circulation, JACC, and AIDS. I established the HIV Cardiology Clinic at San Francisco General Hospital and am one of the few cardiologists internationally with clinical as well as research expertise in this area.


Disclosures:

P. Hsue, Gilead: honoraria , Speaker honorarium . Pfizer: honoraria , Speaker honorarium . Sanofi/Regeneron: received study drug and placebo for NIH funded clinical trial , study drug and placebo for NIH funded trial . Novartis: received study drug and placebo for NIH funded clinical trial , study drug and placebo for NIH trial .

See more of: HIV State of the Art
See more of: Symposium
<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.